GlassScriptPhysician profile
Nicole Colucci
NPI 1215387386
$36,278.00
in general payments reported to CMS, 2019-2025
37 companies · $8,418 in 2025
The $8,418 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,915 · 2022: $5,004 · 2023: $9,988 · 2024: $8,953 · 2025: $8,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,475 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,628 · Honoraria: $1,500 · Consulting Fee: $884 · Travel and Lodging: $552 · Education: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,882.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,475.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,628.00 |
| Honoraria | $1,500.00 |
| Consulting Fee | $884.00 |
| Travel and Lodging | $552.05 |
| Education | $438.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $10,675.49 | 2021-2025 | Ilumya, Blu-U, Odomzo |
| Abbvie INC. | $2,597.13 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $2,006.40 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,834.53 | 2021-2025 | Jublia, Arazlo, Duobrii |
| Regeneron Healthcare Solutions, INC. | $1,651.19 | 2021-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $1,651.10 | 2022-2024 | Vtama |
| Lilly USA, LLC | $1,477.68 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $1,473.37 | 2022-2025 | Sotyktu |
| Amgen INC. | $1,435.93 | 2021-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $1,378.04 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Galderma Laboratories, L.P. | $1,289.05 | 2021-2025 | Aklief, Nemluvio, Oracea |
| Novartis Pharmaceuticals Corporation | $1,225.46 | 2021-2025 | |
| Almirall LLC | $1,068.75 | 2021-2025 | Klisyri, Seysara |
| Arcutis Biotherapeutics, INC. | $994.17 | 2023-2025 | Zoryve |
| Ucb, INC. | $882.86 | 2021-2025 | Bimzelx, Cimzia |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $825.82 | 2022-2025 | Opzelura |
| Leo Pharma INC. | $671.78 | 2021-2023 | Adbry |
| Journey Medical Corporation | $546.73 | 2021-2025 | |
| Vyne Pharmaceuticals INC. | $513.47 | 2021 | |
| Genzyme Corporation | $449.86 | 2021-2025 | |
| Organon LLC | $372.11 | 2025 | Vtama |
| Pfizer INC. | $334.39 | 2021-2025 | |
| Convatec INC. | $284.52 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $116.67 | 2021 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Epi Health, LLC | $95.05 | 2021-2022 | |
| Genentech USA, INC. | $66.08 | 2021-2025 | Xolair, Erivedge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.75 | 2022 | |
| Boston Scientific Corporation | $43.71 | 2022-2025 | General - Vascular Intervention |
| Botanix Sb INC | $37.37 | 2025 | Sofdra |
| Biofrontera INC. | $25.89 | 2021 | |
| Ani Pharmaceuticals, INC. | $18.25 | 2025 | Oxistat |
| Biocon Biologics INC | $16.96 | 2025 | Yesintek |
| Verrica Pharmaceuticals INC. | $15.07 | 2023 | Ycanth |
| Nabriva Therapeutics, Plc | $15.00 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $14.71 | 2022 | |
| Allergan, INC. | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Colucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.